Original Research

Published on 26 Feb 2024

Omega-conotoxin MVIIA reduces neuropathic pain after spinal cord injury by inhibiting N-type voltage-dependent calcium channels on spinal dorsal horn

in Neuropharmacology

Nobuko Ohashi
Daisuke Uta
Masayuki Ohashi
Rintaro Hoshino
Hiroshi Baba

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1366829

1,011 views

Review

Published on 19 Feb 2024

Hypothermia and temperature modulation for intracerebral hemorrhage (ICH): pathophysiology and translational applications

in Neuropharmacology

Angel J. Cadena
Fred Rincon

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1289705

1,579 views

Mini Review

Published on 14 Feb 2024

Tetrahydrocannabinol and dopamine D1 receptor

in Neuropharmacology

Jiwon Lee

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1360205

2,632 views
1 citation

Original Research

Published on 07 Feb 2024

Methylone is a rapid-acting neuroplastogen with less off-target activity than MDMA

in Neuropharmacology

Jennifer Warner-Schmidt
Martin Stogniew
Blake Mandell
R. Scott Rowland
Eric F. Schmidt
Benjamin Kelmendi

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1353131

2,530 views

Clinical Trial

Published on 01 Feb 2024

Pharmacokinetics and pharmacodynamics across infusion rates of intravenously administered nipocalimab: results of a phase 1, placebo-controlled study

in Neuropharmacology

Jocelyn H. Leu
An Vermeulen
Claudia Abbes
Santiago Arroyo
William S. Denney
Leona E. Ling

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1302714

3,020 views
1 citation

Editorial

Published on 30 Jan 2024

Editorial: New drugs, approaches and strategies for multiple sclerosis treatment

in Neuropharmacology

Rafael Coveñas
Pilar Marcos
Arturo Mangas

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1372140

1,371 views

Original Research

Published on 29 Jan 2024

Phosphosulindac (OXT-328) prevents and reverses chemotherapy induced peripheral neuropathy in mice

in Neuropharmacology

Aryah Basu
Jennifer Y. Yang
Vasiliki E. Tsirukis
Andrew Loiacono
Gina Koch
Ishan A. Khwaja
Mahila Krishnamurthy
Nicholas Fazio
Emily White
Aayushi Jha

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1240372

1,667 views

Brief Research Report

Published on 24 Jan 2024

The projection from dorsal medial prefrontal cortex to basolateral amygdala promotes behaviors of negative emotion in rats

in Neuropharmacology

Youqing Cai
Jianlong Ge
Zhizhong Z. Pan

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1331864

1,305 views

Original Research

Published on 24 Jan 2024

Levetiracetam modulates brain metabolic networks and transcriptomic signatures in the 5XFAD mouse model of Alzheimer’s disease

in Neuropharmacology

Charles P. Burton
Evgeny J. Chumin
Alyssa Y. Collins
Scott A. Persohn
Kristen D. Onos
Ravi S. Pandey
Sara K. Quinney
Paul R. Territo

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1336026

1,427 views
1 citation

Systematic Review

Published on 16 Jan 2024

Efficacy and safety of zuranolone in the treatment of major depressive disorder: a meta-analysis

in Neuropharmacology

Shuyu Wang
Wenxing Zhang
Zhang Liu
Tian Zhang
Yi Wang
Weihong Li

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1332329

1,813 views
1 citation

Brief Research Report

Published on 12 Jan 2024

Propofol-induced anesthesia involves the direct inhibition of glutamatergic neurons in the lateral hypothalamus

in Neuropharmacology

Yan Huang
Yong Xiao
Linji Li
Xinglong Feng
Weixing Ding
Feng Cai

Frontiers in Neuroscience

doi 10.3389/fnins.2024.1327293

1,125 views
1 citation

Original Research

Published on 12 Jan 2024

Neuroprotective effect of ranolazine improves behavioral discrepancies in a rat model of scopolamine-induced dementia

in Neuropharmacology

Shereen M. Samir
Hend M. Hassan
Rasha Elmowafy
Eman Mohamed ElNashar
Mansour Abdullah Alghamdi
Mona Hmoud AlSheikh
Norah Saeed Al-Zahrani
Faten Mohammed Alasiri
Mona G. Elhadidy

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1267675

1,612 views

Editorial

Published on 09 Jan 2024

Editorial: Glutamatergic system in affective and psychotic disorders: pre-clinical and clinical advances

in Neuropharmacology

Dominik Strzelecki
Monika Talarowska
Jakub Kaźmierski
Napoleon Waszkiewicz
David Curtis

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1358271

827 views

Original Research

Published on 05 Dec 2023

Cross-validation of the ego dissolution scale: implications for studying psychedelics

in Neuropharmacology

Steven Jay Lynn
Charlie W. McDonald
Fiona G. Sleight
Richard E. Mattson

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1267611

2,709 views
1 citation

Original Research

Published on 01 Dec 2023

Anxiolytic and antidepressant like effects of Zamzam water in STZ-induced diabetic rats, targeting oxidative stress, neuroinflammation, BDNF/ERK/CREP pathway with modulation of hypothalamo-pituitary–adrenal axis

in Neuropharmacology

Medhat Taha
Mohamed Ezzat Mahmoud
Abdullah G. Al-Kushi
Anas Sarhan
Omer Abdelbagi
Tourki A. S. Baokbah
Omar Babateen
Ibrahim El-Shenbaby
Naeem F. Qusty
Sara T. Elazab

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1265134

2,731 views

Brief Research Report

Published on 30 Nov 2023

Fibroblast growth factor 13-mediated regulation of medium spiny neuron excitability and cocaine self-administration

in Neuropharmacology

Nolan M. Dvorak
Jessica Di Re
Tileena E. S. Vasquez
Mate Marosi
Poonam Shah
Yorkiris M. Mármol Contreras
Matteo Bernabucci
Aditya K. Singh
Jariatu Stallone
Thomas A. Green

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1294567

1,442 views

Navigation group

Articles

Omega-conotoxin MVIIA reduces neuropathic pain after spinal cord injury by inhibiting N-type voltage-dependent calcium channels on spinal dorsal horn

Hypothermia and temperature modulation for intracerebral hemorrhage (ICH): pathophysiology and translational applications

Tetrahydrocannabinol and dopamine D1 receptor

Methylone is a rapid-acting neuroplastogen with less off-target activity than MDMA

Pharmacokinetics and pharmacodynamics across infusion rates of intravenously administered nipocalimab: results of a phase 1, placebo-controlled study

Editorial: New drugs, approaches and strategies for multiple sclerosis treatment

Phosphosulindac (OXT-328) prevents and reverses chemotherapy induced peripheral neuropathy in mice

The projection from dorsal medial prefrontal cortex to basolateral amygdala promotes behaviors of negative emotion in rats

Levetiracetam modulates brain metabolic networks and transcriptomic signatures in the 5XFAD mouse model of Alzheimer’s disease

Efficacy and safety of zuranolone in the treatment of major depressive disorder: a meta-analysis

Propofol-induced anesthesia involves the direct inhibition of glutamatergic neurons in the lateral hypothalamus

Neuroprotective effect of ranolazine improves behavioral discrepancies in a rat model of scopolamine-induced dementia

Editorial: Glutamatergic system in affective and psychotic disorders: pre-clinical and clinical advances

Cross-validation of the ego dissolution scale: implications for studying psychedelics

Anxiolytic and antidepressant like effects of Zamzam water in STZ-induced diabetic rats, targeting oxidative stress, neuroinflammation, BDNF/ERK/CREP pathway with modulation of hypothalamo-pituitary–adrenal axis

Fibroblast growth factor 13-mediated regulation of medium spiny neuron excitability and cocaine self-administration